Acid ceramidase (N-acylsphingosine deacylase, EC 3.5.1.23) is the lysosomal enzyme catalyzing the hydrolysis of ceramide to sphingosine and free fatty acid, Its inherited deficiency causes ceramide accumulation in Farber's disease. The enzyme was purified to apparent homogeneity from human urine by sequential chromatography on octyl-Sepharose, concanavalin A-Sepharose, blue-Sepharose, and DEAE-cellulose. The final preparation, which was enriched similar to 4450-fold over the starting material, resulted in a polypeptide of similar to 50 kDa and could be reduced into two subunits of similar to 13 (alpha) and similar to 40 (beta) kDa. Treatment of the purified enzyme with endoglycosidase H or peptide-N-glycanase F reduced the molecular mass of the beta subunit to similar to 30-35 and similar to 27 kDa, respectively. In contrast, the molecular mass of the alpha subunit was unchanged, The purified enzyme had an apparent K-m of 149 mu M and a V-max of 136 nmol/mg/h using N-lauroylsphingosine as substrate. Polyclonal antibodies were raised against the purified urinary enzyme and used to investigate the biosynthesis of acid ceramidase. Immunoprecipitation studies on metabolically labeled skin fibroblasts indicated that both subunits arose from a single precursor of similar to 55 kDa. A minor portion of newly synthesized acid ceramidase was secreted into the me dium as a monomeric 47-kDa protein, indicating that generation of the mature heterodimeric enzyme occurred in endosomal and/or lysosomal compartments.